Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study

Detalles Bibliográficos
Autores principales: Hafner, Roderick Peter, Patel, Piyush, Salapatek, Annemarie, Laidler, Paul, Larché, Mark, Patel, Deepen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643727/
http://dx.doi.org/10.1186/1939-4551-6-S1-P150
_version_ 1782268363844616192
author Hafner, Roderick Peter
Patel, Piyush
Salapatek, Annemarie
Laidler, Paul
Larché, Mark
Patel, Deepen
author_facet Hafner, Roderick Peter
Patel, Piyush
Salapatek, Annemarie
Laidler, Paul
Larché, Mark
Patel, Deepen
author_sort Hafner, Roderick Peter
collection PubMed
description
format Online
Article
Text
id pubmed-3643727
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36437272013-05-08 Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study Hafner, Roderick Peter Patel, Piyush Salapatek, Annemarie Laidler, Paul Larché, Mark Patel, Deepen World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643727/ http://dx.doi.org/10.1186/1939-4551-6-S1-P150 Text en Copyright ©2013 Hafner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Hafner, Roderick Peter
Patel, Piyush
Salapatek, Annemarie
Laidler, Paul
Larché, Mark
Patel, Deepen
Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
title Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
title_full Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
title_fullStr Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
title_full_unstemmed Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
title_short Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
title_sort immunotherapy – 2067. fel d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643727/
http://dx.doi.org/10.1186/1939-4551-6-S1-P150
work_keys_str_mv AT hafnerroderickpeter immunotherapy2067feld1peptideantigendesensitizationsafetyandefficacyinadoubleblindplacebocontrolledenvironmentalexposurechamberstudy
AT patelpiyush immunotherapy2067feld1peptideantigendesensitizationsafetyandefficacyinadoubleblindplacebocontrolledenvironmentalexposurechamberstudy
AT salapatekannemarie immunotherapy2067feld1peptideantigendesensitizationsafetyandefficacyinadoubleblindplacebocontrolledenvironmentalexposurechamberstudy
AT laidlerpaul immunotherapy2067feld1peptideantigendesensitizationsafetyandefficacyinadoubleblindplacebocontrolledenvironmentalexposurechamberstudy
AT larchemark immunotherapy2067feld1peptideantigendesensitizationsafetyandefficacyinadoubleblindplacebocontrolledenvironmentalexposurechamberstudy
AT pateldeepen immunotherapy2067feld1peptideantigendesensitizationsafetyandefficacyinadoubleblindplacebocontrolledenvironmentalexposurechamberstudy

Ejemplares similares